Notwithstanding, LINC00152 and LINC01013 expression have been correlated with poor prognosis in diverse human cancer types, including acute myeloid leukemia [27,29,47], supporting the potential role of both genes in ALL as risk predictors of poor outcomes. This evidence concerns the gene LINC01013 and cancer.